Jacobs Levy Equity Management’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-195,320
| Closed | -$7.06M | – | 1090 |
|
|
2023
Q2 | $7.06M | Buy |
195,320
+10,604
| +6% | +$383K | 0.04% | 328 |
|
|
2023
Q1 | $6.87M | Buy |
184,716
+142,694
| +340% | +$5.31M | 0.04% | 343 |
|
|
2022
Q4 | $1.9M | Buy |
+42,022
| New | +$1.9M | 0.01% | 563 |
|
|
2021
Q1 | – | Sell |
-914
| Closed | -$201K | – | 1140 |
|
|
2020
Q4 | $201K | Buy |
+914
| New | +$201K | ﹤0.01% | 964 |
|
|
2018
Q3 | – | Sell |
-23,500
| Closed | -$1.16M | – | 1096 |
|
|
2018
Q2 | $1.16M | Hold |
23,500
| – | – | 0.02% | 631 |
|
|
2018
Q1 | $721K | Sell |
23,500
-5,000
| -18% | -$153K | 0.01% | 705 |
|
|
2017
Q4 | $520K | Buy |
28,500
+5,000
| +21% | +$91.2K | 0.01% | 744 |
|
|
2017
Q3 | $275K | Buy |
23,500
+12,300
| +110% | +$144K | 0.01% | 805 |
|
|
2017
Q2 | $41K | Buy |
+11,200
| New | +$41K | ﹤0.01% | 911 |
|